| OPKO HEALTH INC. DL-,01 |
| USA |
| Gesundheit |
| US68375N1037 / A0MUUJ |
| XCY (Frankfurt) / OPK (NASDAQ) |
| FRA:XCY, ETR:XCY, XCY:GR, NASDAQ:OPK |
| - |
| https://www.opko.com/ |
|
OPKO Health, Inc. is a diversified healthcare company focused on diagnostics and pharmaceuticals. Through its Diagnostics segment, the company provides clinical laboratory and genetic testing services, including BioReference Health and specialized as..
>Volltext.. |
| 883.17 Mio. EUR |
| 968.71 Mio. EUR |
| 527.03 Mio. EUR |
| -70.08 Mio. EUR |
| -65.34 Mio. EUR |
| -0.09 EUR |
| 356.87 Mio. EUR |
| 269.62 Mio. EUR |
| -110.61 Mio. EUR |
| 2.01 |
| -8.67% |
| 57.56% |
| - |
| - |
| - |
| - |
| OPKO HEALTH |
| 16.10.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|